Status:
COMPLETED
Perianastomotic Drain After Gastrectomy (DRAG)
Lead Sponsor:
THEODOROU DIMITRIOS
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Gastric cancer ranks as the fifth most common and fifth most lethal cancer globally. For patients with AJCC stages IB to IIIC, representing the majority of cases, the current gold standard of surgical...
Detailed Description
The DRAG (DRains After Gastrectomy) Trial is a prospective, non-randomized, controlled clinical trial involving patients diagnosed with gastric neoplasm. All surgeries were performed by a single, high...
Eligibility Criteria
Inclusion
- Age over 18 years old
- Histologically proven EGJ (Siewert II or III) or non-EGJ gastric adenocarcinoma (intestinal, diffuse, or mixed Lauren type)
- Surgical candidates for total gastrectomy plus D2 lymph node dissection
- ECOG performance status 0 or 1
- Signed informed consent from
- Preoperative evaluation of cTanyNanyM0 according to the American Joint Committee on Cancer Staging Manual, 7th edition
Exclusion
- M1 disease
- Other unplanned organ excision
- Massive ascites or cachexia
- Current participation in any other clinical trial
- Severe cardiovascular, respiratory tract, kidney, liver, or psychiatric disease.
- Poor compliance to the clinical protocol
- Pregnancy
Key Trial Info
Start Date :
February 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04288661
Start Date
February 28 2020
End Date
June 30 2024
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hippocration General Hospital
Athens, Greece, 11527